Shares of Merck rose 2.7 percent intraday Wednesday after Merck Specialties received government approval to buy company's biopharmaceuticals business.
The Department of Pharmaceuticals, Ministry of Chemicals and Fertilizers, Government of India, has approved the proposal of Merck Specialties for acquisition of the biopharmaceuticals business of the company by Merck Specialties by way of a slump sale.
At 13:26 hrs Merck was quoting at Rs 2,981.90, up Rs 76.95, or 2.65 percent.
The share touched its 52-week high Rs 3,549 and 52-week low Rs 1,041.25 on 03 September, 2018 and 07 December, 2017, respectively.
Currently, it is trading 15.98 percent below its 52-week high and 186.38 percent above its 52-week low.
For more market news, click here
Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!
